Structure Therapeutics Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ null, null, 149.12, 445.56, 1349.57 ], "ebit_estimate": [ -397.88, -477.38, -471.83, -401.44, -88.53 ], "ebitda_estimate": [ -376.58, -420.83, -436.51, -321.53, 365.12 ], "net_income_estimate": [ -354.79, -439.49, -450.97, -414.59, -182.09 ], "per_share_eps_estimate": [ -1.66, -2.14, -2.18, -2.05, -1.21 ], "eps_nri_estimate": [ -1.63, -2.05, -1.97, -2.09, -1.21 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 11.08, 7.55, 2.62, null, null ], "pretax_income_estimate": [ -362.05, -440.33, -453.75, -343.41, 52.93 ], "operating_cash_flow_per_share_estimate": [ -3.1, -5.22, null, null, null ], "roa_estimate": [ -25.5, -38.3, null, null, null ], "roe_estimate": [ -25.53, -39, -42.68, null, null ], "gross_margin_estimate": [ null, null, 95, 86, 92 ], "operating_cash_flow_estimate": [ -224.57, -378.15, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": -18.24, "future_ebitda_estimate_growth": -30.72, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -44.74, "future_pretax_income_estimate_growth": -44.9, "future_book_value_per_share_estimate_growth": -28.75, "future_roa_estimate_growth": null, "future_roe_estimate_growth": -53.21, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ null, null, null, null, null, null, null, null ], "ebit_estimate": [ -94.36, -103.85, -110.87, -114.12, -119.14, -123.22, -127.45, null ], "ebitda_estimate": [ -92.22, -96.73, -100.7, null, null, null, null, null ], "net_income_estimate": [ -85.14, -95.17, -102.89, -101.33, -106.99, -111.68, -116.48, null ], "per_share_eps_estimate": [ -0.4, -0.43, -0.46, -0.46, -0.48, -0.51, -0.75, null ], "eps_nri_estimate": [ -0.39, -0.43, -0.45, -0.46, -0.48, -0.51, -0.75, -0.6 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ -85.65, -96.79, -104.88, -101.33, -106.99, -111.68, -116.48, null ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ -23.66, -25.29, -27.19, null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": -18.24, "future_ebitda_estimate_growth": -30.72, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -44.74, "future_pretax_income_estimate_growth": -44.9, "future_book_value_per_share_estimate_growth": -28.75, "future_roa_estimate_growth": null, "future_roe_estimate_growth": -53.21, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }